135 related articles for article (PubMed ID: 2208160)
21. Aromatase is the major enzyme metabolizing buprenorphine in human placenta.
Deshmukh SV; Nanovskaya TN; Ahmed MS
J Pharmacol Exp Ther; 2003 Sep; 306(3):1099-105. PubMed ID: 12808001
[TBL] [Abstract][Full Text] [Related]
22. Substituted C19 steroid analogs as inhibitors of aromatase.
Brueggemeier RW; Snider CE; Counsell RE
Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of aromatase activity and expression in MCF-7 cells by the chemopreventive retinoid N-(4-hydroxy-phenyl)-retinamide.
Ciolino HP; Wang TT; Sathyamoorthy N
Br J Cancer; 2000 Aug; 83(3):333-7. PubMed ID: 10917548
[TBL] [Abstract][Full Text] [Related]
24. Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.
Santner SJ; Rosen H; Osawa Y; Santen RJ
J Steroid Biochem; 1984 Jun; 20(6A):1239-42. PubMed ID: 6748639
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture.
Yue W; Brodie AM
J Steroid Biochem Mol Biol; 1997; 63(4-6):317-28. PubMed ID: 9459198
[TBL] [Abstract][Full Text] [Related]
26. Ovine placental aromatase: studies of activity levels, kinetic characteristics and effects of aromatase inhibitors.
France JT; Mason JI; Magness RR; Murry BA; Rosenfeld CR
J Steroid Biochem; 1987 Aug; 28(2):155-60. PubMed ID: 3626552
[TBL] [Abstract][Full Text] [Related]
27. [The inhibitory effect of miconazole on aromatase activity for androstenedione in human placental and ovarian preparations].
Yamamoto T; Urabe M; Okada H
Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1379-85. PubMed ID: 3443212
[TBL] [Abstract][Full Text] [Related]
28. Novel 19-(cyclopropylamino)-androst-4-en-3,17-dione: a mechanism-based inhibitor of aromatase.
Njar VC; Düerkop J; Hartmann RW
J Enzyme Inhib; 1996; 10(1):47-56. PubMed ID: 8835929
[TBL] [Abstract][Full Text] [Related]
29. Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: a new system for aromatase inhibitor screening.
Kitawaki J; Kim T; Kanno H; Noguchi T; Yamamoto T; Okada H
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):667-70. PubMed ID: 8476780
[TBL] [Abstract][Full Text] [Related]
30. Lack of evidence for aromatase expression in human ovarian epithelial carcinoma.
Imai A; Ohno T; Takahashi K; Furui T; Tamaya T
Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():65-71. PubMed ID: 8154854
[TBL] [Abstract][Full Text] [Related]
31. Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308----Phe, Tyr-361----Phe, Tyr-361----Leu, and Phe-406----Arg.
Zhou DJ; Pompon D; Chen SA
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):410-4. PubMed ID: 1988941
[TBL] [Abstract][Full Text] [Related]
32. [Estrogen formation in the central nervous system and characteristics of aromatase of rat hypothalamus].
Takezawa Y; Fukabori Y; Honma S
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):96-110. PubMed ID: 2040368
[TBL] [Abstract][Full Text] [Related]
33. In vitro kinetic properties of the Thr201Met variant of human aromatase gene CYP19A1: functional responses to substrate and product inhibition and enzyme inhibitors.
Payne EJ; Ingley E; Dick IM; Wilson SG; Bond CS; Prince RL
J Clin Endocrinol Metab; 2009 Aug; 94(8):2998-3002. PubMed ID: 19470632
[TBL] [Abstract][Full Text] [Related]
34. A radiometric assay method for aromatase activity using [1 beta-3H]16 alpha-hydroxyandrostenedione.
Numazawa M; Mutsumi A; Nakakoshi M; Nagaoka M
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1839-42. PubMed ID: 1394701
[TBL] [Abstract][Full Text] [Related]
35. Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn, and Asp309Ala and their interactions with aromatase inhibitors.
Kadohama N; Yarborough C; Zhou D; Chen S; Osawa Y
J Steroid Biochem Mol Biol; 1992 Dec; 43(7):693-701. PubMed ID: 1472461
[TBL] [Abstract][Full Text] [Related]
36. Selective aromatase inhibition by pyridoglutethimide, an analogue of aminoglutethimide.
Kitawaki J; Yamamoto T; Urabe M; Tamura T; Inoue S; Honjo H; Okada H
Acta Endocrinol (Copenh); 1990 May; 122(5):592-8. PubMed ID: 2353556
[TBL] [Abstract][Full Text] [Related]
37. Aromatase inhibition in JAr choriocarcinoma cells by 7alpha-arylaliphatic androgens.
Brueggemeier RW; Gilbert NE; Gu X; O'Reilly JM; Lovely CJ
J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):73-7. PubMed ID: 9328212
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships of the inhibition of human placental aromatase by imidazole drugs including ketoconazole.
Ayub M; Levell MJ
J Steroid Biochem; 1988 Jul; 31(1):65-72. PubMed ID: 3398530
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the aromatase cytochrome P450 gene in human breast cancers.
Sourdaine P; Parker MG; Telford J; Miller WR
J Mol Endocrinol; 1994 Dec; 13(3):331-7. PubMed ID: 7893351
[TBL] [Abstract][Full Text] [Related]
40. Catalytic differences between porcine blastocyst and placental aromatase isozymes.
Kao YC; Higashiyama T; Sun X; Okubo T; Yarborough C; Choi I; Osawa Y; Simmen FA; Chen S
Eur J Biochem; 2000 Oct; 267(20):6134-9. PubMed ID: 11012665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
